Cargando…

Potential benefit of hormonal therapy for non-uterine soft tissue sarcoma (STS) – a case report and literature review

The expression of hormone receptors (HR) is considered a good prognostic marker in uterine sarcoma. Hormonal therapy is widely employed in the therapy of HR positive breast and gynecologic cancers, however, there is little information concerning hormonal therapy in HR positive extrauterine sarcoma....

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Li, Schuster, Isaiah P, Jacob, Robin, Hupart, Kenneth H, Gotlieb, Vladimir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2013
Materias:	Case Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3825229/ https://www.ncbi.nlm.nih.gov/pubmed/24255838 http://dx.doi.org/10.1186/2193-1801-2-536

Ejemplares similares

Phenoxy herbicides, chlorophenols, soft-tissue sarcoma (STS) and malignant lymphoma.
por: Hardell, L.
Publicado: (1993)

Evaluation of the accuracy of algorithms to identify soft tissue sarcoma (STS) in administrative claims
por: Princic, Nicole, et al.
Publicado: (2020)

A phase II study of ENMD-2076 in advanced soft tissue sarcoma (STS)
por: Veitch, Zachary, et al.
Publicado: (2019)

A Phase II Study of Docetaxel and Epirubicin in Advanced Adult Soft Tissue Sarcomas (STS)
por: Kalofonos, Haralabos P., et al.
Publicado: (2004)

Treatment patterns and survival in an exhaustive French cohort of pazopanib-eligible patients with metastatic soft tissue sarcoma (STS)
por: Ray-Coquard, Isabelle, et al.
Publicado: (2017)

Electronic Patient Reported Outcome (ePRO) Measures in Patients with Soft Tissue Sarcoma (STS) Receiving Palliative Treatment
por: Hofer, Silvia, et al.
Publicado: (2023)

CINSARC in high‐risk soft tissue sarcoma patients treated with neoadjuvant chemotherapy: Results from the ISG‐STS 1001 study
por: Frezza, Anna Maria, et al.
Publicado: (2022)

Axitinib in patients with advanced/metastatic soft tissue sarcoma (Axi-STS): an open-label, multicentre, phase II trial in four histological strata
por: Woll, Penella J., et al.
Publicado: (2023)

TIM-3 Qualifies as a Potential Immunotherapeutic Target in Specific Subsets of Patients with High-Risk Soft Tissue Sarcomas (HR-STS)
por: Berclaz, Luc M., et al.
Publicado: (2023)

Hormonal therapy in uterine sarcomas
por: Zang, Yuqin, et al.
Publicado: (2019)

Inhibition of AKT-Signaling Sensitizes Soft Tissue Sarcomas (STS) and Gastrointestinal Stromal Tumors (GIST) to Doxorubicin via Targeting of Homology-Mediated DNA Repair
por: Boichuk, Sergei, et al.
Publicado: (2020)

CUL4A, ERCC5, and ERCC1 as Predictive Factors for Trabectedin Efficacy in Advanced Soft Tissue Sarcomas (STS): A Spanish Group for Sarcoma Research (GEIS) Study
por: Moura, David S., et al.
Publicado: (2020)

Clinical Benefit of Second-Line Palliative Chemotherapy in Advanced Soft-Tissue Sarcoma
por: Minchom, Anna, et al.
Publicado: (2010)

Trabectedin in Soft Tissue Sarcomas
por: Petek, Bradley J., et al.
Publicado: (2015)

Clustering of cancer among families of cases with Hodgkin Lymphoma (HL), Multiple Myeloma (MM), Non-Hodgkin's Lymphoma (NHL), Soft Tissue Sarcoma (STS) and control subjects
por: McDuffie, Helen H, et al.
Publicado: (2009)

Alternative splicing of Apoptosis Stimulating Protein of TP53-2 (ASPP2) results in an oncogenic isoform promoting migration and therapy resistance in soft tissue sarcoma (STS)
por: Tsintari, Vasileia, et al.
Publicado: (2022)

Fine-Needle Aspiration Cytology of Soft Tissue Sarcoma: Benefits and Limitations
por: Åkerman, Måns
Publicado: (1998)

Pazopanib in advanced soft tissue sarcomas
por: Lee, Alex T. J., et al.
Publicado: (2019)

Efficacy of Eribulin in Soft Tissue Sarcomas
por: Phillips, Edward, et al.
Publicado: (2022)

Margin Assessment in Soft Tissue Sarcomas: Review of the Literature
por: Sambri, Andrea, et al.
Publicado: (2021)

The proteomic landscape of soft tissue sarcomas
por: Burns, Jessica, et al.
Publicado: (2023)

Alveolar Soft Part Sarcoma of the Uterine Cervix: A Case Report and Review of the Literature
por: Lee, Hyun Ju
Publicado: (2014)

Soft-tissue Sarcomas
por: Vodanovich, Domagoj Ante, et al.
Publicado: (2018)

New Insights into Hormonal Therapies in Uterine Sarcomas
por: Maccaroni, Elena, et al.
Publicado: (2022)

BRCA1 haplotype and clinical benefit of trabectedin in soft-tissue sarcoma patients
por: Laroche-Clary, A, et al.
Publicado: (2015)

The Phosphatases STS1 and STS2 Regulate Hematopoietic Stem and Progenitor Cell Fitness
por: Zhang, Jing, et al.
Publicado: (2015)

Value of peri-operative chemotherapy in patients with CINSARC high-risk localized grade 1 or 2 soft tissue sarcoma: study protocol of the target selection phase III CHIC-STS trial
por: Filleron, Thomas, et al.
Publicado: (2020)

Retroperitoneal soft tissue sarcoma
por: Zepeda, Ernesto, et al.
Publicado: (2007)

Soft Tissue Sarcomas of the Kidney
por: Köhle, Olivia, et al.
Publicado: (2015)

Bone and Soft Tissue Sarcoma
por: Ruggiero, Antonio
Publicado: (2020)

Trabectedin for soft tissue sarcoma
Publicado: (2021)

Significant benefits in survival by the use of surgery combined with radiotherapy for retroperitoneal soft tissue sarcoma
por: Hager, Sven, et al.
Publicado: (2017)

Research Activities in the STS Division
Publicado: (1957)

Research and Development Activities in STS
Publicado: (1957)

Research and Development Activities in STS
Publicado: (1958)

Predictive and prognostic transcriptomic biomarkers in soft tissue sarcomas
por: Merry, Eve, et al.
Publicado: (2021)

STS-1 and STS-2, Multi-Enzyme Proteins Equipped to Mediate Protein–Protein Interactions
por: Hayes, Barbara, et al.
Publicado: (2023)

Brain Metastases in Soft Tissue Sarcomas: Case Report and Literature Review
por: Gupta, Tejpal, et al.
Publicado: (2005)

Advances in the treatment of soft tissue sarcoma: focus on eribulin
por: Koliou, Panagiotis, et al.
Publicado: (2018)

New therapeutics for soft tissue sarcomas: Overview of current immunotherapy and future directions of soft tissue sarcomas
por: Seong, Gyuhee, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4ulfs5bnuob6ms0qffthv5pv2g